Literature DB >> 6134304

Mechanism of anticonvulsant action of valproate.

A Chapman, P E Keane, B S Meldrum, J Simiand, J C Vernieres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6134304     DOI： 10.1016/0301-0082(82)90010-7

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN： 0301-0082            Impact factor:   11.685


× No keyword cloud information.
  62 in total

1.  Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals.

Authors:  P E Keane
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

2.  Inhibition of sterol but not fatty acid synthesis by valproate in developing rat brain in vivo.

Authors:  J P Bolaños; J M Medina; D H Williamson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

3.  Chronic administration of valproic acid induces a decrease in rat striatal glutamate and taurine levels.

Authors:  G B Acosta; S I Wikinski; C C Bonelli; M C Rubio
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

Review 4.  Anticonvulsant drug action and regional neurotransmitter amino acid changes.

Authors:  A G Chapman; G P Hart
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

5.  Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.

Authors:  Preethi Prasad; Hernan Vasquez; Chandra M Das; Vidya Gopalakrishnan; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2008-10-14       Impact factor: 4.130

Review 6.  GABAergic mechanisms in the pathogenesis and treatment of epilepsy.

Authors:  B S Meldrum
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

7.  Sodium valproate: effects on social behaviour and physical development in the mouse.

Authors:  J B Chapman; M G Cutler
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Sodium valproate acutely inhibits lamotrigine metabolism.

Authors:  A W Yuen; G Land; B C Weatherley; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

9.  Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer.

Authors:  Noriyuki Takai; Hisashi Narahara
Journal:  Obstet Gynecol Int       Date:  2010-02-04

10.  Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice.

Authors:  Richard D Beger; Deborah K Hansen; Laura K Schnackenberg; Brandie M Cross; Javad J Fatollahi; F Tracy Lagunero; Zoltan Sarnyai; Laszlo G Boros
Journal:  Metabolomics       Date:  2009-03-31       Impact factor: 4.290
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.